MedPath

Postoperative Pain Management in Patients Undergoing Intramedullary Nail Fixation After Tibia and Femoral Fractures

Phase 4
Completed
Conditions
Tibial Fractures
Femur Fracture
Interventions
Other: Use of non-steroid anti-inflammatory drugs (NSAIDS) as an alternative for post-operative pain management after a femur and tibia fracture
Drug: Intravenous ketorolac and oral acetaminophen
Drug: Intravenous morphine and oral oxycodone
Registration Number
NCT04761302
Lead Sponsor
University of Puerto Rico
Brief Summary

The purpose of this trial is to determine whether oral acetaminophen and intravenous ketorolac are viable alternatives to opioid medication regimens for the pain management of patients with tibial and femoral shaft fractures treated with intramedullary nailing. This study will explore an alternative for opioid medications for patients undergoing intramedullary nailing of tibial and femoral shaft fractures.

Detailed Description

The data analysis for the study will be performed separately for patients with femoral fractures and for patients with tibial fractures. Therefore, the data analysis will compare patients with femoral fractures receiving the experimental treatment to patients with femoral fractures receiving the control treatment (Group 1 vs. Group 2). Likewise, patients with tibial fractures receiving the experimental treatment will be compared to patients with tibial fractures receiving the control treatment (Group 3 vs. Group 4).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
167
Inclusion Criteria
  1. Patients with tibial and femoral shaft fractures
  2. Patients undergoing intramedullary nailing
  3. Willing to participate in the protocol
Exclusion Criteria
  1. Chronic pain disorder (daily use of oral opioids)
  2. Allergy or hypersensitivity to non steroid anti-inflammatory drug
  3. Impaired renal, cardiac, or hepatic function
  4. History of gastrointestinal bleeding or substance abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 1: Intravenous Ketorolac and oral acetaminophenUse of non-steroid anti-inflammatory drugs (NSAIDS) as an alternative for post-operative pain management after a femur and tibia fractureGroup 1 will be composed of patients receiving the following standard pain control protocol: ketorolac 30 mg intravenous (IV) every 6 hours for patients younger than 70 years versus ketorolac 15 mg IV every 6 hours for patients older than 70 years, first dose will be administered 30 minutes preoperatively. An additional 1000mg of oral acetaminophen will be administered every 6 hours simultaneously regardless of the age group. Patients who determine pain to be unbearable and wish to opt out of the non-opioid group will receive may do so.
Group 2: Intravenous Morphine and oral oxycodoneUse of non-steroid anti-inflammatory drugs (NSAIDS) as an alternative for post-operative pain management after a femur and tibia fractureGroup 2 will be composed of patients receiving the following pain control protocol: morphine 0.1 mg per kg intravenous every 6 hours with an additional oral oxycodone combined with acetaminophen 2 tabs every 6 hours.
Group 1: Tibial Fracture Patients Receiving Intravenous Ketorolac and oral acetaminophenIntravenous ketorolac and oral acetaminophenGroup 1 will be composed of tibial fracture patients receiving the following standard pain control protocol: ketorolac 30 mg intravenous (IV) every 6 hours for patients younger than 70 years versus ketorolac 15 mg IV every 6 hours for patients older than 70 years, first dose will be administered 30 minutes preoperatively. An additional 1000mg of oral acetaminophen will be administered every 6 hours simultaneously regardless of the age group. Patients who determine pain to be unbearable and wish to opt out of the non-opioid group will receive may do so.
Group 2: Tibial Fracture Patients Receiving Intravenous Morphine and oral oxycodoneIntravenous morphine and oral oxycodoneGroup 2 will be composed of tibial fracture patients receiving the following pain control protocol: morphine 0.1 mg per kg intravenous every 6 hours with an additional oral oxycodone combined with acetaminophen 2 tabs every 6 hours.
Group 3: Femoral Fracture Patients Receiving Intravenous Ketorolac and Oral AcetaminophenIntravenous ketorolac and oral acetaminophenGroup 3 will be composed of femoral fracture patients receiving the following standard pain control protocol: ketorolac 30 mg intravenous (IV) every 6 hours for patients younger than 70 years versus ketorolac 15 mg IV every 6 hours for patients older than 70 years, first dose will be administered 30 minutes preoperatively. An additional 1000mg of oral acetaminophen will be administered every 6 hours simultaneously regardless of the age group. Patients who determine pain to be unbearable and wish to opt out of the non-opioid group will receive may do so.
Group 4: Femoral Fracture Patients Receiving Intravenous Morphine and oral oxycodoneIntravenous morphine and oral oxycodoneGroup 4 will be composed of femoral fracture patients receiving the following pain control protocol: morphine 0.1 mg per kg intravenous every 6 hours with an additional oral oxycodone combined with acetaminophen 2 tabs every 6 hours.
Primary Outcome Measures
NameTimeMethod
12hrs VAS Pain ScoresMeasured at postoperative hour 12

Visual Analog Scale; 0-10 (10 indicates highest degree of pain)

24hrs VAS Pain ScoreMeasured at postoperative hour 24

Visual Analog Scale; 0 to 10 (10 indicates highest degree of pain)

36hrs VAS Pain ScoresMeasured at postoperative hour 36

Visual Analog Scale; 0-10 (10 indicates highest degree of pain)

48hrs VAS Pain ScoresMeasured at postoperative hour 48

Visual Analog Scale; 0-10 (10 indicates highest degree of pain)

12hrs MMEMeasured at postoperative hour 12

Opioid consumption at postoperative hour 12. Reported as Morphine Milligram Equivalents (MME)

24hrs MMEMeasured at postoperative hour 24

Opioid consumption at postoperative hour 24. Reported as Morphine Milligram Equivalents (MME)

36hrs MMEMeasured at postoperative hour 36

Opioid consumption at postoperative hour 36. Reported as Morphine Milligram Equivalents (MME)

48hrs MMEMeasured at postoperative hour 48

Opioid consumption at postoperative hour 48. Reported as Morphine Milligram Equivalents (MME)

Secondary Outcome Measures
NameTimeMethod
Hospital Length of StayDetermined by discharge date

Time from intervention to discharge

Trial Locations

Locations (1)

University District Hospital

🇵🇷

San Juan, Puerto Rico

University District Hospital
🇵🇷San Juan, Puerto Rico
© Copyright 2025. All Rights Reserved by MedPath